Literature DB >> 23695388

The incidence of mucinous appendiceal malignancies: a population-based study.

M G W van den Heuvel1, V E P P Lemmens, R H A Verhoeven, I H J T de Hingh.   

Abstract

PURPOSE: Mucinous appendiceal tumours were described already 180 years ago, but reliable data on the incidence of these tumours are sparse. The clinical importance of these tumours is increasing since they are now identified as the most common site of origin for pseudomyxoma peritonei (PMP), which is currently recognised as a treatable condition.
METHODS: Data on the incidence of mucinous appendiceal tumours were retrieved from the Eindhoven Cancer Registry, which collects data on all patients with newly diagnosed cancer in a large part of the southern Netherlands that comprises about 2.3 million inhabitants. From 1980 to 2010, all cases of primary adenocarcinomas of the appendix were included.
RESULTS: From 1980 to 2010, a mucinous adenocarcinoma was diagnosed in 78 patients being 48 % of all cases of appendiceal adenocarcinoma diagnosed during this period (n = 164). The incidence increased during the study period from 0.6 to 1.9 per 1,000,000 person-years for women and from 0.4 to 1.0 per 1,000,000 person-years for men.
CONCLUSION: The reported incidence of mucinous adenocarcinomas of the appendix shows an increasing trend. This is probably mainly explained by the increased awareness of this tumour and its relation with PMP, and better registration of this specific diagnosis.

Entities:  

Mesh:

Year:  2013        PMID: 23695388     DOI: 10.1007/s00384-013-1714-9

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  10 in total

1.  Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998.

Authors:  Margaret E McCusker; Timothy R Coté; Limin X Clegg; Leslie H Sobin
Journal:  Cancer       Date:  2002-06-15       Impact factor: 6.860

2.  Importance of histologic subtype in the staging of appendiceal tumors.

Authors:  Kiran K Turaga; Sam G Pappas; T Clark Gamblin
Journal:  Ann Surg Oncol       Date:  2012-05       Impact factor: 5.344

3.  Indication for oophorectomy during cytoreduction for intraperitoneal metastatic spread of colorectal or appendiceal origin.

Authors:  D J Evers; V J Verwaal
Journal:  Br J Surg       Date:  2011-02       Impact factor: 6.939

Review 4.  Pseudomyxoma peritonei.

Authors:  Robert M Smeenk; Sjoerd C Bruin; Marie-Louise F van Velthuysen; Victor J Verwaal
Journal:  Curr Probl Surg       Date:  2008-08       Impact factor: 1.909

5.  Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Terence C Chua; Brendan J Moran; Paul H Sugarbaker; Edward A Levine; Olivier Glehen; François N Gilly; Dario Baratti; Marcello Deraco; Dominique Elias; Armando Sardi; Winston Liauw; Tristan D Yan; Pedro Barrios; Alberto Gómez Portilla; Ignace H J T de Hingh; Wim P Ceelen; Joerg O Pelz; Pompiliu Piso; Santiago González-Moreno; Kurt Van Der Speeten; David L Morris
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

6.  Primary appendiceal carcinoma--epidemiology, surgery and survival: results of a German multi-center study.

Authors:  F Benedix; A Reimer; I Gastinger; P Mroczkowski; H Lippert; R Kube
Journal:  Eur J Surg Oncol       Date:  2010-06-18       Impact factor: 4.424

7.  The natural history of surgically treated primary adenocarcinoma of the appendix.

Authors:  S S Nitecki; B G Wolff; R Schlinkert; M G Sarr
Journal:  Ann Surg       Date:  1994-01       Impact factor: 12.969

8.  Adenocarcinoma of the appendix is rarely detected by colonoscopy.

Authors:  Apurva N Trivedi; Edward A Levine; Girish Mishra
Journal:  J Gastrointest Surg       Date:  2008-12-17       Impact factor: 3.452

Review 9.  Appendix tumors in the era of laparoscopic appendectomy.

Authors:  P Bucher; Z Mathe; A Demirag; Ph Morel
Journal:  Surg Endosc       Date:  2004-05-27       Impact factor: 4.584

10.  Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.

Authors:  R M Smeenk; M L F van Velthuysen; V J Verwaal; F A N Zoetmulder
Journal:  Eur J Surg Oncol       Date:  2007-05-23       Impact factor: 4.424

  10 in total
  9 in total

Review 1.  Appendiceal Mucinous Neoplasms: Diagnosis and Management.

Authors:  Walid L Shaib; Rita Assi; Ali Shamseddine; Olatunji B Alese; Charles Staley; Bahar Memis; Volkan Adsay; Tanios Bekaii-Saab; Bassel F El-Rayes
Journal:  Oncologist       Date:  2017-06-29

2.  FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei.

Authors:  Julien Dubreuil; Francesco Giammarile; Pascal Rousset; Naoual Bakrin; Guillaume Passot; Sylvie Isaac; Olivier Glehen; Andrea Skanjeti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-24       Impact factor: 9.236

Review 3.  Primary and metastatic peritoneal surface malignancies.

Authors:  Delia Cortés-Guiral; Martin Hübner; Mohammad Alyami; Aditi Bhatt; Wim Ceelen; Olivier Glehen; Florian Lordick; Robert Ramsay; Olivia Sgarbura; Kurt Van Der Speeten; Kiran K Turaga; Manish Chand
Journal:  Nat Rev Dis Primers       Date:  2021-12-16       Impact factor: 52.329

4.  Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines.

Authors:  Darren L Roberts; Sarah T O'Dwyer; Peter L Stern; Andrew G Renehan
Journal:  Oncotarget       Date:  2015-05-10

5.  Mucinous appendiceal neoplasm: A case report.

Authors:  Alexandru Chirca; Lucian Negreanu; Andreea Iliesiu; Radu Costea
Journal:  World J Clin Cases       Date:  2021-03-06       Impact factor: 1.337

6.  A case of Pseudomyxoma Peritonei of an unexpected origin.

Authors:  Marie Csanyi-Bastien; France Blanchard; Aude Lamy; Jean-Christophe Sabourin
Journal:  Diagn Pathol       Date:  2021-12-20       Impact factor: 2.644

7.  Demographic trends in the incidence of malignant appendiceal tumours in England between 1995 and 2016: Population-based analysis.

Authors:  Philippa Orchard; Ryan Preece; Michael G Thomas; Steven W Dixon; Newton A C S Wong; Adam C Chambers; David E Messenger
Journal:  BJS Open       Date:  2022-07-07

8.  Trends of incidence and survival in patients with gastrointestinal mucinous adenocarcinoma.

Authors:  Zhen Zong; Yonghui Luo; Houqun Ying; Anan Wang; Hui Li; Chenghao Yi
Journal:  Oncol Lett       Date:  2018-09-04       Impact factor: 2.967

9.  Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report.

Authors:  David Arias Ron; Carmen M Labandeira; Soledad Cameselle García; Jesús García Mata; Mercedes Salgado Fernández
Journal:  Case Rep Oncol       Date:  2020-02-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.